Perceptions of diabetic retinopathy and screening procedures among diabetic people

Diabetic Medicine

Volumn 19, Issue 10, 2002, Pages 810-813

  Trento, M ^a   Bajardi, M ^a   Borgo, E ^a   Passera, P ^a   Maurino, M ^a   Gibbins, R ^b   Owens, D R ^b   Cavallo, F ^c   Porta, M ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b LLANDOUGH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Diabetes; Diabetic retinopathy; Health perceptions; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BLINDNESS; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC RETINOPATHY; EYE INJURY; FEMALE; HEALTH BEHAVIOR; HEALTH CARE; HEALTH EDUCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCEPTION; QUESTIONNAIRE; RETINA; SCREENING;

AGED; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; ITALY; MALE; MIDDLE AGED; PATIENT EDUCATION; RISK; SELF CONCEPT; VISUAL ACUITY; WALES;

EID: 0036400307     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00784.x     Document Type: Article

References (16)

1. Porta M, Tomalino M, Santoro F, Ghigo LD, Cairo M, Aimone M et al. Diabetic retinopathy as a cause of blindness in the province of Turin, North-West Italy, in 1967-1991. Diabet Med 1995; 12: 355-361.
2. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
3. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
4. UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
5. Zhang L, Krzentowski G, Albert A, Lefevbre PJ. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001; 24: 1275-1279.
6. Stefánsson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 2000; 78: 374-385.
7. Pasagian-Macaulay A, Basch CE, Zybert P, Wylie-Rosett J. Ophthalmic knowledge and beliefs among women with diabetes. Diabetes Educ 1997; 23: 433-437.
8. Clark CM, Snyder JW, Meek RL, Stutz LM, Parkin CG. A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care 2001; 24: 1079-1086.
9. Aufseesser M, Lacroix A, Bineyt S, Assal JP. Diabetic retinopathy. Interpretation of medical terms by patients. J Fr Ophthalmol 1995; 18: 27-32.
10. Trento M, Passera P, Tomalino M, Bajardi M, Pomero F, Allione A et al. Group visits improve metabolic control in type 2 diabetes: a two-year follow-up. Diabetes Care 2001; 24: 995-1000.
11. Rosenstock IM. Why people use health services. Milbank Mem Fund Q 1966; 44: 94-127.
12. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q 1988; 15: 175-183.
13. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 1975; 13: 10-24.
14. Rotter JB. Generalized expectancies for internal versus external control of reinforcement. Psycholol Monogr 1966; 80: 1-28.
15. Taylor R, Broadbent DM, Greenwood R, Hepburn D, Owens DR, Simpson H. Mobile retinal screening in Britain. Diabet Med 1998; 15: 344-347.
16. Kohner EM, Porta M. Screening for Diabetic Retinopathy in Europe: A Field Guide-book. Copenhagen: WHO-Regional Office for Europe, 1992; 1-51.